Vertex Pharmaceuticals Incorporated:企業の戦略・SWOT・財務分析

【英語タイトル】Vertex Pharmaceuticals Incorporated - Strategy, SWOT and Corporate Finance Report

MarketLineが出版した調査資料(MLINE7097445)・商品コード:MLINE7097445
・発行会社(調査会社):MarketLine
・発行日:2017年1月31日
・ページ数:48
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・産業分野:医療・製薬
◆販売価格オプション(消費税別)
Single UserUSD175 ⇒換算¥19,775見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD350 ⇒換算¥39,550見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD525 ⇒換算¥59,325見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000を加算
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

SummaryVertex Pharmaceuticals Incorporated – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Findings
- Detailed information on Vertex Pharmaceuticals Incorporated required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Vertex Pharmaceuticals Incorporated in the form of a SWOT analysis
- An in-depth view of the business model of Vertex Pharmaceuticals Incorporated including a breakdown and examination of key business segments
- Intelligence on Vertex Pharmaceuticals Incorporated’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Vertex Pharmaceuticals Incorporated, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons To Buy
- Gain understanding of Vertex Pharmaceuticals Incorporated and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Vertex Pharmaceuticals Incorporated as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Vertex Pharmaceuticals Incorporated’s business structure, strategy and prospects.

Key Highlights
Vertex Pharmaceuticals Incorporated (Vertex or ‘the company’) is a biotechnology company engaged in the discovery, development and commercialization of new medicines. The company primarily operates in the US, Canada and Europe. It is headquartered in Boston, Massachusetts, and employed approximately 1,830 people as on December 31, 2014.

【レポートの目次】

Company Snapshot
Vertex Pharmaceuticals Incorporated: Company Overview
Vertex Pharmaceuticals Incorporated: Overview and Key Facts
Vertex Pharmaceuticals Incorporated: Overview
Vertex Pharmaceuticals Incorporated: Key Facts
Vertex Pharmaceuticals Incorporated: Key Employees
Vertex Pharmaceuticals Incorporated: Key Employee Biographies
Vertex Pharmaceuticals Incorporated: Major Products and Services
Vertex Pharmaceuticals Incorporated: Company History
Vertex Pharmaceuticals Incorporated: Management Statement
Vertex Pharmaceuticals Incorporated: Locations and Subsidiaries
Vertex Pharmaceuticals Incorporated: Key Competitors
Vertex Pharmaceuticals Incorporated: Company Analysis
Vertex Pharmaceuticals Incorporated: Business Description
Vertex Pharmaceuticals Incorporated: SWOT Analysis
Vertex Pharmaceuticals Incorporated: SWOT Overview
Vertex Pharmaceuticals Incorporated: Strengths
Vertex Pharmaceuticals Incorporated: Weaknesses
Vertex Pharmaceuticals Incorporated: Opportunities
Vertex Pharmaceuticals Incorporated: Threats
Vertex Pharmaceuticals Incorporated: Corporate Financial Deals Activity
Vertex Pharmaceuticals Incorporated: Financial Deals Overview
Vertex Pharmaceuticals Incorporated: Targets and Partners
Vertex Pharmaceuticals Incorporated: Top Deals 2013 – 2017YTD*
Vertex Pharmaceuticals Incorporated: Corporate Venturing
Vertex Pharmaceuticals Incorporated: Partnership
Vertex Pharmaceuticals Incorporated: Recent Developments
Vertex Pharmaceuticals Incorporated: News and Events Summary
Vertex Pharmaceuticals Incorporated: Contracts
Vertex Pharmaceuticals Incorporated: Corporate Governance
Vertex Pharmaceuticals Incorporated: Financial Performance
Vertex Pharmaceuticals Incorporated: Regulatory and Legal Events
Vertex Pharmaceuticals Incorporated: Research and Development
Vertex Pharmaceuticals Incorporated: Strategy and Operations
Appendix
Contact Us
Methodology
Definitions
About Datamonitor

Table 1: Vertex Pharmaceuticals Incorporated: Key Facts
Table 2: Vertex Pharmaceuticals Incorporated: Key Employees
Table 4: Vertex Pharmaceuticals Incorporated: Key Competitors
Table 5: Vertex Pharmaceuticals Incorporated: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Vertex Pharmaceuticals Incorporated: Deal Activity by Deal Type - Volume (2013 - YTD*2017)
Table 7: Vertex Pharmaceuticals Incorporated: Targets and Partners
Table 8: Vertex Pharmaceuticals Incorporated: Top Deals 2013 - 2017YTD*
Table 9: Vertex Pharmaceuticals Incorporated: Corporate Venturing Volume and Value Trend (2013 - YTD*2017)
Table 10: Vertex Pharmaceuticals Incorporated: Partnership Volume and Value Trend (2013 - YTD*2017)
Table 11: Vertex Pharmaceuticals Incorporated: Partnership Trend by Deal Type (2013 - YTD*2017)
Table 12: Vertex Pharmaceuticals Incorporated: News and Events Summary
Table 13: Vertex Pharmaceuticals Incorporated: Contracts
Table 14: Vertex Pharmaceuticals Incorporated: Corporate Governance
Table 15: Vertex Pharmaceuticals Incorporated: Financial Performance
Table 16: Vertex Pharmaceuticals Incorporated: Regulatory and Legal Events
Table 17: Vertex Pharmaceuticals Incorporated: Research and Development
Table 18: Vertex Pharmaceuticals Incorporated: Strategy and Operations

Figure 1: Vertex Pharmaceuticals Incorporated: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Vertex Pharmaceuticals Incorporated: Deal Activity by Deal Type - Volume (2013 - YTD*2017)
Figure 3: Vertex Pharmaceuticals Incorporated: Corporate Venturing Volume and Value Trend (2013 - YTD*2017)
Figure 4: Vertex Pharmaceuticals Incorporated: Partnership Volume and Value Trend (2013 - YTD*2017)
Figure 5: Vertex Pharmaceuticals Incorporated: Partnership Trend by Deal Type (2013 - YTD*2017)

★調査レポート[Vertex Pharmaceuticals Incorporated:企業の戦略・SWOT・財務分析] (コード:MLINE7097445)販売に関する免責事項を必ずご確認ください。
★調査レポート[Vertex Pharmaceuticals Incorporated:企業の戦略・SWOT・財務分析]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆